With markets still volatile, keep your portfolio protected with high-yielding exchange-traded funds. Look at the Amplify CWP ...

Trump has again threatened the multibillion-dollar pharmaceutical sector with high tariffs unless they move production to the U.S.

The new futures-based ETFs aim to deliver 2x daily returns on SOL and XRP as spot ETF proposals await SEC decisions, ...

ProShares introduces futures XRP ETF and SOL ETF designed to deliver 2x the daily performance of SOL and XRP, targeting ...

The ProShares Ultra XRP ETF is expected to start trading on NYSE Arca from July 18. XRP broke above $2.92 following the ...

ProShares has released two new ETFs giving investors heightened exposure to the performance of XRP and Solana using leverage.

A generous grace period would give drugmakers time to sidestep most of the pain of looming duties.

ProShares Ultra XRP ETF receives NYSE Arca approval, offering leveraged 2x daily exposure to XRP price via futures-based ...

NYSE Arca approves ProShares Ultra XRP and Ultra Solana ETFs, offering 2x leveraged exposure. Here’s what it means for crypto investors.

Three major bills could send Bitcoin-related exchange-traded funds (ETFs) screaming higher. That includes: The Digital Asset ...

The SEC just approved the ProShares Ultra XRP ETF for listing on NYSE Arca. Here’s what the launch means for XRP's price and Ripple investors.

The US SEC has officially approved the ProShares Ultra XRP ETF, and it is set to launch on the NYSE Arca this week.